Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | Phlpp2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of PHLPP2 mRNA | CTD | PMID:28189721 and PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | Phlpp2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of PHLPP2 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of PHLPP2 mRNA | CTD | PMID:29097150 | 17beta-estradiol | increases expression | ISO | PHLPP2 (Homo sapiens) | 6480464 | Estradiol results in increased expression of PHLPP2 mRNA | CTD | PMID:31614463 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PHLPP2 mRNA | CTD | PMID:33387578 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | PHLPP2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PHLPP2 mRNA | CTD | PMID:28628672 | acetaldehyde | decreases expression | ISO | PHLPP2 (Homo sapiens) | 6480464 | Acetaldehyde results in decreased expression of PHLPP2 mRNA | CTD | PMID:23416264 | aflatoxin B1 | increases expression | ISO | Phlpp2 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of PHLPP2 mRNA | CTD | PMID:19770486 | aflatoxin B1 | increases methylation | ISO | PHLPP2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of PHLPP2 gene | CTD | PMID:27153756 | all-trans-retinoic acid | decreases expression | ISO | PHLPP2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of PHLPP2 mRNA | CTD | PMID:33167477 | arecoline | multiple interactions | ISO | PHLPP2 (Homo sapiens) | 6480464 | [arecoline hydrobromide results in increased abundance of Arecoline] which results in increased expression of PHLPP2 mRNA and PHLPP2 protein affects the reaction [[arecoline hydrobromide results in increased abundance of Arecoline] which results in decreased phosphorylation of AKT1 protein] | CTD | PMID:30910432 | aristolochic acid A | decreases expression | ISO | PHLPP2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of PHLPP2 mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | PHLPP2 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to PHLPP2 mRNA] | CTD | PMID:32406909 | atrazine | decreases expression | ISO | PHLPP2 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of PHLPP2 mRNA | CTD | PMID:22378314 | benzene | increases expression | ISO | PHLPP2 (Homo sapiens) | 6480464 | Benzene results in increased expression of PHLPP2 mRNA | CTD | PMID:19162166 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PHLPP2 mRNA | CTD | PMID:25181051 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of PHLPP2 mRNA | CTD | PMID:32145629 | bisphenol F | multiple interactions | ISO | PHLPP2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PHLPP2 mRNA | CTD | PMID:28628672 | CGP 52608 | multiple interactions | ISO | PHLPP2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to PHLPP2 gene] | CTD | PMID:28238834 | chromium(6+) | affects expression | ISO | Phlpp2 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of PHLPP2 mRNA | CTD | PMID:28472532 | cisplatin | multiple interactions | ISO | PHLPP2 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of PHLPP2 mRNA | CTD | PMID:27392435 | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of PHLPP2 mRNA | CTD | PMID:20187946 | copper atom | multiple interactions | ISO | PHLPP2 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of PHLPP2 mRNA | CTD | PMID:30911355 | copper(0) | multiple interactions | ISO | PHLPP2 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of PHLPP2 mRNA | CTD | PMID:30911355 | cyclosporin A | decreases expression | ISO | PHLPP2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of PHLPP2 mRNA | CTD | PMID:27989131 | dexamethasone | multiple interactions | ISO | PHLPP2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PHLPP2 mRNA | CTD | PMID:28628672 | dioxygen | multiple interactions | ISO | Phlpp2 (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [PHLPP2 protein affects the reaction [Oxygen deficiency results in increased activity of CASP3 protein]] more ... | CTD | PMID:31610156 | dioxygen | increases expression | ISO | Phlpp2 (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of PHLPP2 mRNA and Oxygen deficiency results in increased expression of PHLPP2 protein | CTD | PMID:31610156 | formaldehyde | decreases expression | ISO | PHLPP2 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of PHLPP2 mRNA | CTD | PMID:20655997 | indometacin | multiple interactions | ISO | PHLPP2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PHLPP2 mRNA | CTD | PMID:28628672 | lead(0) | decreases expression | ISO | PHLPP2 (Homo sapiens) | 6480464 | Lead results in decreased expression of PHLPP2 mRNA | CTD | PMID:19921347 | monosodium L-glutamate | decreases expression | ISO | Phlpp2 (Mus musculus) | 6480464 | Sodium Glutamate results in decreased expression of PHLPP2 mRNA | CTD | PMID:22078008 | monosodium L-glutamate | multiple interactions | ISO | Phlpp2 (Mus musculus) | 6480464 | [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PHLPP2 mRNA | CTD | PMID:22078008 | morin | multiple interactions | EXP | | 6480464 | morin inhibits the reaction [Acetaminophen results in increased expression of PHLPP2 protein] | CTD | PMID:26767949 | paracetamol | affects expression | ISO | Phlpp2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of PHLPP2 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | PHLPP2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of PHLPP2 mRNA | CTD | PMID:26690555 | paracetamol | multiple interactions | EXP | | 6480464 | morin inhibits the reaction [Acetaminophen results in increased expression of PHLPP2 protein] | CTD | PMID:26767949 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of PHLPP2 protein | CTD | PMID:26767949 | paracetamol | increases expression | ISO | PHLPP2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of PHLPP2 mRNA | CTD | PMID:21420995 | pirinixic acid | multiple interactions | ISO | PHLPP2 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PHLPP2 mRNA | CTD | PMID:19710929 | rotenone | increases expression | ISO | Phlpp2 (Mus musculus) | 6480464 | Rotenone results in increased expression of PHLPP2 mRNA | CTD | PMID:32937126 | sodium arsenite | decreases expression | ISO | Phlpp2 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of PHLPP2 protein | CTD | PMID:21268130 | sodium arsenite | increases methylation | ISO | PHLPP2 (Homo sapiens) | 6480464 | sodium arsenite results in increased methylation of PHLPP2 mRNA | CTD | PMID:36444808 | sodium arsenite | multiple interactions | ISO | PHLPP2 (Homo sapiens) | 6480464 | sodium arsenite promotes the reaction [FTO protein binds to PHLPP2 mRNA] more ... | CTD | PMID:36444808 | sodium arsenite | decreases expression | ISO | PHLPP2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of PHLPP2 protein | CTD | PMID:36444808 | sunitinib | increases expression | ISO | PHLPP2 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of PHLPP2 mRNA | CTD | PMID:31533062 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of PHLPP2 mRNA | CTD | PMID:31150632 | urethane | increases expression | ISO | PHLPP2 (Homo sapiens) | 6480464 | Urethane results in increased expression of PHLPP2 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | PHLPP2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of PHLPP2 mRNA | CTD | PMID:23179753 more ... | valproic acid | affects expression | ISO | PHLPP2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of PHLPP2 mRNA | CTD | PMID:25979313 | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of PHLPP2 mRNA | CTD | PMID:29427782 | |